biomarker

Adjuvant chemotherapy in gastric adenocarcinoma

Blood and tissue TMB in predicting response to immunotherapy

Optimal chemotherapy combinations in TNBC gBRCA subtypes

Combining checkpoint blockade therapies in melanoma

Serum NSE levels as a biomarker in MCC

Targeting PSMA in mCRPC

SPORT: P-SABR versus PPN-SABR for localized prostate cancer

The SMART study: IRE in pancreatic cancer

CONVERSION from unresectable to resectable mCRC in real-world patients

ctDNA as a novel biomarker for MRD in CRC

First-line treatment guidelines: combination strategy

NIVOREN GETUG-AFU 26: Updates and implications

The value of PD-L1 as a biomarker beyond lung cancers

OpACIn-neo trial RFS and biomarker analyses: optimal neoadjuvant ipi/nivo dosing in melanoma

Biomarker-directed BISCAY data: durvalumab plus targeted therapies in mUC

Vinorelbine in Mesothelioma: the upcoming VIM trial